Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6909
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Mitsubishi Tanabe Pharma Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Mitsubishi Tanabe Pharma Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe or ‘the company’), a subsidiary of Mitsubishi Chemical Holdings Corp manufactures and sells ethical pharmaceuticals. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also manufactures products for various infectious diseases. Mitsubishi Tanabe’s offers its products under brands such as Maintate, Tenelia, Remicade Simponi, Radicut, Ceredist, Lexapro, Nanpao, Talion, Flucort F, and Tetrabik. The company markets its products to wholesalers, hospitals, clinics, and drugstores. The company operates research centers in Saitama, Kanagawa and Osaka. The company has operations across Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Scope

- Detailed information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Mitsubishi Tanabe Pharma Corporation including a breakdown and examination of key business segments
- Intelligence on Mitsubishi Tanabe Pharma Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mitsubishi Tanabe Pharma Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mitsubishi Tanabe Pharma Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Mitsubishi Tanabe Pharma Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Mitsubishi Tanabe Pharma Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Mitsubishi Tanabe Pharma Corporation: Company Overview 9
Mitsubishi Tanabe Pharma Corporation: Overview and Key Facts 9
Mitsubishi Tanabe Pharma Corporation: Overview 9
Mitsubishi Tanabe Pharma Corporation: Key Facts 9
Mitsubishi Tanabe Pharma Corporation: Key Employees 11
Mitsubishi Tanabe Pharma Corporation: Key Employee Biographies 13
Mitsubishi Tanabe Pharma Corporation: Major Products and Services 16
Mitsubishi Tanabe Pharma Corporation: Company History 17
Mitsubishi Tanabe Pharma Corporation: Management Statement 23
Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries 30
Mitsubishi Tanabe Pharma Corporation: Key Competitors 31
Mitsubishi Tanabe Pharma Corporation: Company Analysis 32
Mitsubishi Tanabe Pharma Corporation: Business Description 32
Mitsubishi Tanabe Pharma Corporation: SWOT Analysis 33
Mitsubishi Tanabe Pharma Corporation: SWOT Overview 33
Mitsubishi Tanabe Pharma Corporation: Strengths 33
Mitsubishi Tanabe Pharma Corporation: Weaknesses 33
Mitsubishi Tanabe Pharma Corporation: Opportunities 34
Mitsubishi Tanabe Pharma Corporation: Threats 34
Mitsubishi Tanabe Pharma Corporation: Corporate Financial Deals Activity 36
Mitsubishi Tanabe Pharma Corporation: Financial Deals Overview 36
Mitsubishi Tanabe Pharma Corporation: Targets and Partners 38
Mitsubishi Tanabe Pharma Corporation: Top Deals 2014 – 2018YTD* 39
Mitsubishi Tanabe Pharma Corporation: Mergers and Acquisitions 40
Mitsubishi Tanabe Pharma Corporation: Partnership 41
Mitsubishi Tanabe Pharma Corporation: Divestments 42
Mitsubishi Tanabe Pharma Corporation: Recent Developments 43
Mitsubishi Tanabe Pharma Corporation: News and Events Summary 43
Mitsubishi Tanabe Pharma Corporation: Business Expansion 47
Mitsubishi Tanabe Pharma Corporation: Contracts 48
Mitsubishi Tanabe Pharma Corporation: Corporate Governance 48
Mitsubishi Tanabe Pharma Corporation: Financial Performance 49
Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events 50
Mitsubishi Tanabe Pharma Corporation: Research & Development 51
Mitsubishi Tanabe Pharma Corporation: Strategy and Operations 51
Appendix 53
Contact Us 53
Methodology 53
About MarketLine 54

List of Tables
Table 1: Mitsubishi Tanabe Pharma Corporation: Key Facts
Table 2: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 3: Mitsubishi Tanabe Pharma Corporation: Company History
Table 4: Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries
Table 5: Mitsubishi Tanabe Pharma Corporation: Key Competitors
Table 6: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (TTM*)
Table 8: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Mitsubishi Tanabe Pharma Corporation: M&A Average Deal Size - Value (US$m)
Table 10: Mitsubishi Tanabe Pharma Corporation: Targets and Partners
Table 11: Mitsubishi Tanabe Pharma Corporation: Top Deals 2014 - 2018YTD*
Table 12: Mitsubishi Tanabe Pharma Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2014 - YTD*2018)
Table 18: Mitsubishi Tanabe Pharma Corporation: News and Events Summary
Table 19: Mitsubishi Tanabe Pharma Corporation: Business Expansion
Table 20: Mitsubishi Tanabe Pharma Corporation: Contracts
Table 21: Mitsubishi Tanabe Pharma Corporation: Corporate Governance
Table 22: Mitsubishi Tanabe Pharma Corporation: Financial Performance
Table 23: Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events
Table 24: Mitsubishi Tanabe Pharma Corporation: Research & Development
Table 25: Mitsubishi Tanabe Pharma Corporation: Strategy and Operations

List of Figures
Figure 1: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (TTM*)
Figure 3: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Mitsubishi Tanabe Pharma Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: Mitsubishi Tanabe Pharma Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orbit International Corp.:企業の戦略・SWOT・財務情報
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bharat Petroleum Corp Ltd (BPCL):石油・ガス:M&Aディール及び事業提携情報
    Summary Bharat Petroleum Corp Ltd (BPCL) is an integrated oil and gas company. It carries out production of oil and natural gas; refining of crude oil; and marketing and distribution of petroleum products. The company also focuses on renewable energy. It produces oil products including light distill …
  • Enerjisa Enerji Uretim AS:発電所・企業SWOT分析
    Enerjisa Enerji Uretim AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • CLP Holdings Ltd (00002):電力:M&Aディール及び事業提携情報
    Summary CLP Holdings Ltd (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s generatio …
  • Novolex Holdings, Inc.:企業の戦略的SWOT分析
    Novolex Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Banyan Tree Holdings Ltd:企業の戦略・SWOT・財務情報
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • T-Mobile US, Inc.:企業の戦略・SWOT・財務情報
    T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report Summary T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Broadcom Inc:企業の戦略・SWOT・財務情報
    Broadcom Inc - Strategy, SWOT and Corporate Finance Report Summary Broadcom Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Atomic Energy of Canada Ltd:企業の戦略的SWOT分析
    Atomic Energy of Canada Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • PGE Polska Grupa Energetyczna SA (PGE):電力:M&Aディール及び事業提携情報
    Summary PGE Polska Grupa Energetyczna SA (PGE SA) is a state owned energy utility. It generates, trades, transmits, and distributes electricity. The company carries out lignite mining activities, electricity generation from fossil fuels (lignite, hard coal, and natural gas) and renewable energy sour …
  • E.ON UK Plc:企業の戦略的SWOT分析
    E.ON UK Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Eurobio Scientific SA (ALEHT):企業の財務・戦略的SWOT分析
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. …
  • Sprint Bioscience AB (SPRINT):企業の財務・戦略的SWOT分析
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Microchip Technology Incorporated:企業のM&A・事業提携・投資動向
    Microchip Technology Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microchip Technology Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Warburg Pincus LLC:戦略・SWOT・企業財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Transocean Ltd.:戦略・SWOT・企業財務分析
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Korea Gas Corp (036460)-石油・ガス分野:企業M&A・提携分析
    Summary Korea Gas Corp (KOGAS) is a vertically integrated natural gas company active in upstream midstream and downstream segments of natural gas industry. It explores, produces and distributes natural gas. The company also purifies and sells by-products; imports and exports natural gas and liquefie …
  • Fives:企業の戦略・SWOT・財務分析
    Fives - Strategy, SWOT and Corporate Finance Report Summary Fives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆